THERMO FISHER SCIENTIFIC INC (TN8.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:TN8 • US8835561023

456.2 EUR
-2.6 (-0.57%)
Last: Feb 9, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to TN8. TN8 was compared to 21 industry peers in the Life Sciences Tools & Services industry. TN8 has an average financial health and profitability rating. TN8 is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • TN8 had positive earnings in the past year.
  • In the past year TN8 had a positive cash flow from operations.
  • Each year in the past 5 years TN8 has been profitable.
  • Each year in the past 5 years TN8 had a positive operating cash flow.
TN8.DE Yearly Net Income VS EBIT VS OCF VS FCFTN8.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 6.08%, TN8 is in the better half of the industry, outperforming 61.90% of the companies in the same industry.
  • TN8 has a better Return On Equity (12.55%) than 61.90% of its industry peers.
  • TN8 has a Return On Invested Capital (6.00%) which is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for TN8 is below the industry average of 10.06%.
Industry RankSector Rank
ROA 6.08%
ROE 12.55%
ROIC 6%
ROA(3y)6.22%
ROA(5y)6.79%
ROE(3y)12.72%
ROE(5y)14.58%
ROIC(3y)6.18%
ROIC(5y)6.93%
TN8.DE Yearly ROA, ROE, ROICTN8.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 15.05%, TN8 belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
  • In the last couple of years the Profit Margin of TN8 has declined.
  • With a decent Operating Margin value of 18.19%, TN8 is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • TN8's Operating Margin has declined in the last couple of years.
  • TN8 has a Gross Margin of 41.22%. This is comparable to the rest of the industry: TN8 outperforms 47.62% of its industry peers.
  • TN8's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 18.19%
PM (TTM) 15.05%
GM 41.22%
OM growth 3Y-1.32%
OM growth 5Y-5.71%
PM growth 3Y-0.93%
PM growth 5Y-5.33%
GM growth 3Y-0.55%
GM growth 5Y-3.49%
TN8.DE Yearly Profit, Operating, Gross MarginsTN8.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TN8 is destroying value.
  • TN8 has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for TN8 has been reduced compared to 5 years ago.
  • The debt/assets ratio for TN8 is higher compared to a year ago.
TN8.DE Yearly Shares OutstandingTN8.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
TN8.DE Yearly Total Debt VS Total AssetsTN8.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • TN8 has a debt to FCF ratio of 6.26. This is a slightly negative value and a sign of low solvency as TN8 would need 6.26 years to pay back of all of its debts.
  • The Debt to FCF ratio of TN8 (6.26) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.67 indicates that TN8 is somewhat dependend on debt financing.
  • TN8's Debt to Equity ratio of 0.67 is in line compared to the rest of the industry. TN8 outperforms 52.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 6.26
Altman-Z N/A
ROIC/WACC0.57
WACC10.61%
TN8.DE Yearly LT Debt VS Equity VS FCFTN8.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • A Current Ratio of 1.89 indicates that TN8 should not have too much problems paying its short term obligations.
  • TN8's Current ratio of 1.89 is amongst the best of the industry. TN8 outperforms 80.95% of its industry peers.
  • TN8 has a Quick Ratio of 1.53. This is a normal value and indicates that TN8 is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of TN8 (1.53) is better than 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.53
TN8.DE Yearly Current Assets VS Current LiabilitesTN8.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • TN8 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.62%.
  • TN8 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.19% yearly.
  • TN8 shows a small growth in Revenue. In the last year, the Revenue has grown by 3.91%.
  • TN8 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.70% yearly.
EPS 1Y (TTM)4.62%
EPS 3Y-0.53%
EPS 5Y3.19%
EPS Q2Q%7.7%
Revenue 1Y (TTM)3.91%
Revenue growth 3Y-0.27%
Revenue growth 5Y6.7%
Sales Q2Q%7.2%

3.2 Future

  • Based on estimates for the next years, TN8 will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.96% on average per year.
  • Based on estimates for the next years, TN8 will show a small growth in Revenue. The Revenue will grow by 4.93% on average per year.
EPS Next Y8.54%
EPS Next 2Y9%
EPS Next 3Y9.51%
EPS Next 5Y10.96%
Revenue Next Year5.68%
Revenue Next 2Y5.47%
Revenue Next 3Y5.78%
Revenue Next 5Y4.93%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TN8.DE Yearly Revenue VS EstimatesTN8.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
TN8.DE Yearly EPS VS EstimatesTN8.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 23.71, which indicates a rather expensive current valuation of TN8.
  • Based on the Price/Earnings ratio, TN8 is valued a bit cheaper than the industry average as 61.90% of the companies are valued more expensively.
  • TN8's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.06.
  • With a Price/Forward Earnings ratio of 21.85, TN8 is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, TN8 is valued a bit cheaper than the industry average as 61.90% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of TN8 to the average of the S&P500 Index (27.86), we can say TN8 is valued slightly cheaper.
Industry RankSector Rank
PE 23.71
Fwd PE 21.85
TN8.DE Price Earnings VS Forward Price EarningsTN8.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • TN8's Enterprise Value to EBITDA is on the same level as the industry average.
  • TN8's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 32.37
EV/EBITDA 21.38
TN8.DE Per share dataTN8.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TN8 does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.78
PEG (5Y)7.44
EPS Next 2Y9%
EPS Next 3Y9.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.32%, TN8 is not a good candidate for dividend investing.
  • TN8's Dividend Yield is comparable with the industry average which is at 0.44.
  • With a Dividend Yield of 0.32, TN8 pays less dividend than the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 0.32%

5.2 History

  • The dividend of TN8 is nicely growing with an annual growth rate of 14.69%!
Dividend Growth(5Y)14.69%
Div Incr Years4
Div Non Decr Years4
TN8.DE Yearly Dividends per shareTN8.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • TN8 pays out 9.49% of its income as dividend. This is a sustainable payout ratio.
  • TN8's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP9.49%
EPS Next 2Y9%
EPS Next 3Y9.51%
TN8.DE Yearly Income VS Free CF VS DividendTN8.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
TN8.DE Dividend Payout.TN8.DE Dividend Payout, showing the Payout Ratio.TN8.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

THERMO FISHER SCIENTIFIC INC

FRA:TN8 (2/9/2026, 7:00:00 PM)

456.2

-2.6 (-0.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-29
Earnings (Next)04-21
Inst Owners92.78%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap171.40B
Revenue(TTM)44.56B
Net Income(TTM)6.70B
Analysts83.13
Price Target571.83 (25.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.32%
Yearly Dividend1.43
Dividend Growth(5Y)14.69%
DP9.49%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.64%
Min EPS beat(2)0.91%
Max EPS beat(2)4.37%
EPS beat(4)3
Avg EPS beat(4)1.7%
Min EPS beat(4)-0.07%
Max EPS beat(4)4.37%
EPS beat(8)6
Avg EPS beat(8)2.42%
EPS beat(12)7
Avg EPS beat(12)1.02%
EPS beat(16)11
Avg EPS beat(16)2.83%
Revenue beat(2)2
Avg Revenue beat(2)1.08%
Min Revenue beat(2)0.95%
Max Revenue beat(2)1.21%
Revenue beat(4)4
Avg Revenue beat(4)0.77%
Min Revenue beat(4)0.28%
Max Revenue beat(4)1.21%
Revenue beat(8)6
Avg Revenue beat(8)0.22%
Revenue beat(12)7
Avg Revenue beat(12)-0.27%
Revenue beat(16)11
Avg Revenue beat(16)1.95%
PT rev (1m)3.51%
PT rev (3m)6.38%
EPS NQ rev (1m)-5.63%
EPS NQ rev (3m)-5.68%
EPS NY rev (1m)-0.17%
EPS NY rev (3m)0.76%
Revenue NQ rev (1m)-1.29%
Revenue NQ rev (3m)-1.25%
Revenue NY rev (1m)0.66%
Revenue NY rev (3m)1.51%
Valuation
Industry RankSector Rank
PE 23.71
Fwd PE 21.85
P/S 4.57
P/FCF 32.37
P/OCF 26.06
P/B 3.81
P/tB N/A
EV/EBITDA 21.38
EPS(TTM)19.24
EY4.22%
EPS(NY)20.88
Fwd EY4.58%
FCF(TTM)14.09
FCFY3.09%
OCF(TTM)17.51
OCFY3.84%
SpS99.77
BVpS119.61
TBVpS-26.39
PEG (NY)2.78
PEG (5Y)7.44
Graham Number227.55
Profitability
Industry RankSector Rank
ROA 6.08%
ROE 12.55%
ROCE 8.52%
ROIC 6%
ROICexc 6.71%
ROICexgc 28.75%
OM 18.19%
PM (TTM) 15.05%
GM 41.22%
FCFM 14.13%
ROA(3y)6.22%
ROA(5y)6.79%
ROE(3y)12.72%
ROE(5y)14.58%
ROIC(3y)6.18%
ROIC(5y)6.93%
ROICexc(3y)6.79%
ROICexc(5y)7.57%
ROICexgc(3y)30.99%
ROICexgc(5y)35.86%
ROCE(3y)8.78%
ROCE(5y)9.93%
ROICexgc growth 3Y-13.91%
ROICexgc growth 5Y-12.87%
ROICexc growth 3Y-6.93%
ROICexc growth 5Y-10.12%
OM growth 3Y-1.32%
OM growth 5Y-5.71%
PM growth 3Y-0.93%
PM growth 5Y-5.33%
GM growth 3Y-0.55%
GM growth 5Y-3.49%
F-Score5
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF 6.26
Debt/EBITDA 3.29
Cap/Depr 54.86%
Cap/Sales 3.42%
Interest Coverage 250
Cash Conversion 71.83%
Profit Quality 93.88%
Current Ratio 1.89
Quick Ratio 1.53
Altman-Z N/A
F-Score5
WACC10.61%
ROIC/WACC0.57
Cap/Depr(3y)47.77%
Cap/Depr(5y)61.4%
Cap/Sales(3y)3.38%
Cap/Sales(5y)4.31%
Profit Quality(3y)108.05%
Profit Quality(5y)102.29%
High Growth Momentum
Growth
EPS 1Y (TTM)4.62%
EPS 3Y-0.53%
EPS 5Y3.19%
EPS Q2Q%7.7%
EPS Next Y8.54%
EPS Next 2Y9%
EPS Next 3Y9.51%
EPS Next 5Y10.96%
Revenue 1Y (TTM)3.91%
Revenue growth 3Y-0.27%
Revenue growth 5Y6.7%
Sales Q2Q%7.2%
Revenue Next Year5.68%
Revenue Next 2Y5.47%
Revenue Next 3Y5.78%
Revenue Next 5Y4.93%
EBIT growth 1Y5.05%
EBIT growth 3Y-1.59%
EBIT growth 5Y0.61%
EBIT Next Year19.29%
EBIT Next 3Y11.41%
EBIT Next 5Y10.61%
FCF growth 1Y-13.39%
FCF growth 3Y-3.07%
FCF growth 5Y-1.58%
OCF growth 1Y-9.78%
OCF growth 3Y-5.12%
OCF growth 5Y-1.16%

THERMO FISHER SCIENTIFIC INC / TN8.DE FAQ

What is the fundamental rating for TN8 stock?

ChartMill assigns a fundamental rating of 4 / 10 to TN8.DE.


What is the valuation status for TN8 stock?

ChartMill assigns a valuation rating of 3 / 10 to THERMO FISHER SCIENTIFIC INC (TN8.DE). This can be considered as Overvalued.


What is the profitability of TN8 stock?

THERMO FISHER SCIENTIFIC INC (TN8.DE) has a profitability rating of 5 / 10.


Can you provide the financial health for TN8 stock?

The financial health rating of THERMO FISHER SCIENTIFIC INC (TN8.DE) is 4 / 10.


Can you provide the dividend sustainability for TN8 stock?

The dividend rating of THERMO FISHER SCIENTIFIC INC (TN8.DE) is 3 / 10 and the dividend payout ratio is 9.49%.